Search for: "Lisa Ouellette"
Results 101 - 120
of 169
Sorted by Relevance
|
Sort by Date
20 Jan 2015, 8:38 am
— Lisa L. [read post]
3 Feb 2016, 11:40 am
And in the few circumstances where that is not true – where inventions truly are "singletons" – it is often because of an accident or error in the experiment rather than a conscious effort to invent.In spite of Lemley's explicit reference to "bamboo" in the abstract of his law review, Lisa Larrimore Ouellette wrote:Lemley isn't making any claims about the scope of the patents these inventors received, so whether "bamboo" appears… [read post]
2 Feb 2016, 12:24 pm
Student editors are unlikely to have strong familiarity with the technical concepts that form the subject of many law review articles in the area of intellectual property.The previous post on IPBiz had allluded to some of the problems in the textSeparately, some commentary from Lisa Larrimore Ouellette related to Lemley's Myth of the Solo Inventor, and "review" of law review articles:Lemley isn't making any claims about the scope of the patents these inventors… [read post]
5 Jun 2012, 9:46 am
See Lisa Larrimore Ouellette, Do Patents Disclose Useful Information? [read post]
24 Jun 2016, 9:05 am
At Legal Aggregate, Lisa Ouellette analyzes the Court’s recent decision in Cuozzo Speed Technologies v. [read post]
20 Jan 2015, 12:12 pm
Luckily, Lisa Larrimore Ouellette, who runs Written Description, heard about my bloglessness and invited me to join her blog. [read post]
6 Oct 2014, 5:36 am
At Written Description, Lisa Larrimore Ouellette previews next week’s argument in Teva Pharmaceuticals v. [read post]
1 Jun 2017, 4:23 am
” At Stanford Law School’s Legal Aggregate blog, Lisa Larrimore Ouellette looks at the court’s decision inTC Heartland LLC v. [read post]
14 Jan 2019, 2:40 am
(Incidentally, one of the most concise summaries I've ever read of the inconclusive empirical evidence regarding the costs and benefits of patents appears on pages 75-87 of Lisa Larrimore Ouellete's article, Patent Experimentalism.)To some degree, Biagioli's article has a lot in common with these prior articles, expressing skepticism about whether patents and IP, generally, bring benefits that are greater than the costs, and about how society justifies the institution in… [read post]
11 Jun 2020, 2:30 pm
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceOver the past two weeks, the United States—already hit hard by the COVID-19 pandemic—has reckoned with another public health crisis: police violence against Black Americans. [read post]
16 Jun 2020, 6:57 am
Guest post by Jake Linford, Loula Fuller and Dan Myers Professor, Florida State University College of Law, whose trademark law scholarship I have highlighted on JotwellI want to thank Lisa Ouellette for inviting me to blog about United States Patent & Trademark Office v. [read post]
3 Mar 2022, 6:43 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsSince the pandemic began, numerous recovered COVID-19 patients have reported having “long COVID”: COVID-19 symptoms persisting well beyond the underlying viral infection period. [read post]
27 Aug 2021, 12:18 pm
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn previous blog posts in this series, we have explored the roles different federal agencies, including the NIH, FDA, and CMS, play in the development and distribution of new healthcare technologies in the fight against COVID-19. [read post]
18 Feb 2021, 10:24 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn our last post, we introduced some of the clinical evidence supporting the use of therapeutic antibodies against COVID-19—including Regeneron’s casirivimab and imdevimab and Eli Lilly’s bamlanivimab—and analyzed the existing problems in the distribution and administration of those therapies. [read post]
30 Nov 2020, 7:24 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceWhen President-elect Joe Biden is inaugurated in January, his administration will face the ongoing public health and economic challenges created by COVID-19. [read post]
30 Jul 2020, 3:39 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
27 Apr 2020, 1:27 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowHealth systems worldwide are facing shortages of crucial medical supplies, including personal protective equipment (PPE), diagnostic testing components including kits and nasal swabs, and even ventilators or ventilator parts. [read post]
24 Jan 2017, 12:06 pm
Rev. 1525 ] appeared in IPBizSeparately, some commentary from Lisa Larrimore Ouellette related to Lemley's Myth of the Solo Inventor, and "review" of law review articles:Lemley isn't making any claims about the scope of the patents these inventors received, so whether "bamboo" appears in Edison's patent is irrelevant. [read post]
3 May 2021, 8:36 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceWe have written before about the challenges of making decisions under scientific uncertainty and the simultaneous importance and difficulty of developing high-quality clinical evidence under pandemic circumstances. [read post]
18 Dec 2020, 6:37 pm
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsThe past two weeks have been full of exciting COVID-19 vaccine news, including the FDA’s emergency use authorizations (EUAs) for the Pfizer–BioNTech and Moderna vaccines and the nationwide rollout of Pfizer’s vaccine. [read post]
